Apr 14, 2017
In a press release on March 28th, Kemin announced that it has acquired technology to manufacture beta-glucans from Algal Scientific. Kemin anticipates that a new range of products will be available to replace antibiotics.
Dr. Chris Nelson, president and CEO of Kemin Industries noted, “The acquisition of this beta-glucan manufacturing technology will provide Kemin with capabilities and products needed to further expand the antibiotic alternative portfolio for animals and offer important scientific advancements for humans and pets.”
He added “We are focused on ways to rapidly impact our customers’ businesses through strategic acquisitions of differentiating technology.”
John Tucker, CEO of Algal Scientific commented, “Kemin is uniquely suited to exploit this technology offering advanced products to customers globally.”